These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12100798)

  • 61. [Role of embolization in the management of uterine fibroids].
    Kahn V; Fohlen A; Pelage JP
    J Gynecol Obstet Biol Reprod (Paris); 2011 Dec; 40(8):918-27. PubMed ID: 22093440
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship between obesity and uterine leiomyomata.
    Shikora SA; Niloff JM; Bistrian BR; Forse RA; Blackburn GL
    Nutrition; 1991; 7(4):251-5. PubMed ID: 1802214
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surgical and radiological management of uterine fibroids in the UK.
    Chapman L; Magos A
    Curr Opin Obstet Gynecol; 2006 Aug; 18(4):394-401. PubMed ID: 16794419
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.
    Pérez-López FR
    Climacteric; 2015 Apr; 18(2):177-81. PubMed ID: 25390187
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results.
    Fernandez H; Schmidt T; Powell M; Costa AP; Arriagada P; Thaler C
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():91-96. PubMed ID: 27898340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of tamoxifen in the treatment of symptomatic uterine leiomyomata -- a pilot study.
    Sadan O; Ginath S; Sofer D; Rotmensch S; Debby A; Glezerman M; Zakut H
    Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):183-6. PubMed ID: 11384804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata.
    Deligdisch L; Hirschmann S; Altchek A
    Fertil Steril; 1997 May; 67(5):837-41. PubMed ID: 9130887
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnosis and prevalence of uterine leiomyomata in female chimpanzees (Pan troglodytes).
    Videan EN; Satterfield WC; Buchl S; Lammey ML
    Am J Primatol; 2011 Jul; 73(7):665-70. PubMed ID: 21442632
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of uterine fibroids: Approach to medical treatment.
    Huerga López C; Gutiérrez Alagüero A; Cristóbal García I
    Med Clin (Barc); 2023 Oct; 161 Suppl 1():S15-S21. PubMed ID: 37923509
    [No Abstract]   [Full Text] [Related]  

  • 70. Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata.
    Goodwin SC; Bonilla SC; Sacks D; Reed RA; Spies JB; Landow WJ; Worthington-Kirsch RL; ; ;
    J Vasc Interv Radiol; 2003 Sep; 14(9 Pt 2):S467-76. PubMed ID: 14514862
    [No Abstract]   [Full Text] [Related]  

  • 71. Retracted: Clinical Value of Body Mass Index and Waist-Hip Ratio in Clinicopathological Characteristics and Prognosis of Uterine Leiomyomata.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9818725. PubMed ID: 37387823
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Author Correction: Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.
    Gallagher CS; Mäkinen N; Harris HR; Rahmioglu N; Uimari O; Cook JP; Shigesi N; Ferreira T; Velez-Edwards DR; Edwards TL; Mortlock S; Ruhioglu Z; Day F; Becker CM; Karhunen V; Martikainen H; Järvelin MR; Cantor RM; Ridker PM; Terry KL; Buring JE; Gordon SD; Medland SE; Montgomery GW; Nyholt DR; Hinds DA; Tung JY; ; Perry JRB; Lind PA; Painter JN; Martin NG; Morris AP; Chasman DI; Missmer SA; Zondervan KT; Morton CC
    Nat Commun; 2022 Sep; 13(1):5543. PubMed ID: 36130970
    [No Abstract]   [Full Text] [Related]  

  • 73. Multiple leiomyomata.
    Faro S
    Infect Dis Obstet Gynecol; 1997; 5(5):318. PubMed ID: 18476178
    [No Abstract]   [Full Text] [Related]  

  • 74. Multiple Leiomyomata.
    Barber HW
    Proc R Soc Med; 1936 Jun; 29(8):919. PubMed ID: 19990736
    [No Abstract]   [Full Text] [Related]  

  • 75. Pressure-Induced Fibroid Ischemia: First-In-Human Experience with a Novel Device for Laparoscopic Treatment of Symptomatic Uterine Fibroids.
    Tal MG; Keidar R; Magnazi G; Henn O; Kim JH; Chudnoff SG; Stepp KJ
    Reprod Sci; 2023 Apr; 30(4):1366-1375. PubMed ID: 35941511
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CYP24A1 expression analysis in uterine leiomyoma regarding MED12 mutation profile.
    Fazeli E; Piltan S; Gholami M; Akbari M; Falahati Z; Yassaee F; Sadeghi H; Mirfakhraie R
    Arch Gynecol Obstet; 2021 Mar; 303(3):787-792. PubMed ID: 33025089
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization and anti-uterine tumor effect of extract from Prunella vulgaris L.
    Lin Y; Yang C; Tang J; Li C; Zhang ZM; Xia BH; Li YM; He QZ; Lin LM; Liao DF
    BMC Complement Med Ther; 2020 Jun; 20(1):189. PubMed ID: 32552673
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Implementation of the uterine fibroids Option Grid patient decision aids across five organizational settings: a randomized stepped-wedge study protocol.
    Scalia P; Durand MA; Forcino RC; Schubbe D; Barr PJ; O'Brien N; O'Malley AJ; Foster T; Politi MC; Laughlin-Tommaso S; Banks E; Madden T; Anchan RM; Aarts JWM; Velentgas P; Balls-Berry J; Bacon C; Adams-Foster M; Mulligan CC; Venable S; Cochran NE; Elwyn G
    Implement Sci; 2019 Sep; 14(1):88. PubMed ID: 31477140
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada.
    Rattray DD; Weins L; Regush LC; Bowen JM; O'Reilly D; Thiel JA
    Clinicoecon Outcomes Res; 2018; 10():201-212. PubMed ID: 29670382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.